Flash Forward: Cannabis Industry in 2030
When you hear about commercial cannabis “grow-ops,” what comes to mind?
For most people, that question inspires thoughts of lush green fields somewhere out west, being tended by long-haired young people with wheelbarrows and pruning sheers.
It generates mental images of piles and piles of cannabis flower, getting sorted, trimmed, and hung out to dry in metallic barns warmed by the gentle rays of the sun.
It brings to mind scenes from small, cash-only dispensaries that operate somewhere in the gray area of the law, but do so relentlessly to help those in need of alternative medical treatment for otherwise hopeless afflictions.
For most of us, this is how we’ve been conditioned to perceive the business.
It’s natural, it’s organic, it’s low-key and low-tech, and it’s focused on producing and supplying just a few variations of the same basic product.
In many ways, the cannabis industry was and remains nothing more than an offshoot of traditional farming, complete with field hands, farmers markets, and an inevitable dependency on climatic conditions.
But these days, nothing ever stays the same for long... So my second question is, what do you think all of this will look like 10, 15, 20 years from now?
This look into the future may surprise, shock, and, depending on your political views of the plant, even anger you... but this evolution is now under way, and from the look of things, it’s not going to stop.
Take a Trip Through Time
By 2030, your classic image of a commercial cannabis supplier is going to change drastically, taking on many of the characteristics you associate with some of today’s more established mainstream, multinational corporate institutions.
Here's a snapshot:
Our model Cannabis Corporation 2030 will still own and operate large outdoor agricultural properties, but it will also own and operate a variety of indoor growing operations.
It will own grow-houses, where the plant is produced using both traditional and newfangled, hydroponic-based soilless growing methods, where nutrients and water are delivered to the plant through a synthetic matrix that does away with the irregularities and uncertainties associated with the millennia-old natural technique.
Cannabis Corporation 2030 will still derive its products from the cannabis plant but the end products will occupy a broad spectrum, ranging from the natural flower itself to products containing only CBD extract (for those interested in the therapeutic effects and not the recreational) to hemp products and all the way to the hardware designed to imbibe those products.
Multiple Specialties. Multiple Channels. Multiple Nations
There will be candy, condiments, topical lotions, even soft drinks, and each of those product lines will have its own spectrum of potency.
Cannabis Corporation 2030 will still operate on the West Coast of the U.S. and Canada, but it will also be a multinational operation, with properties and facilities in Europe and in other parts of the world.
This company will still employ agricultural workers, but also scientists and genetic engineers whose jobs will focus on boosting output, active ingredient concentrations, and tailoring the products on a molecular level to meet the exacting needs of its end users.
Cannabis Corp. 2030 will continue to produce, refine, and market these products on its own behalf, but it will also lease out its properties and facilities to client entities, allowing for already well-known cannabis brands to extend their reach to new markets.
It will no longer be a simple grow op, but a food company, a hardware company, a scientific incubator, and a real estate management firm, operating in all of its forms across the country and across the world.
Stay on top of the hottest investment ideas before they hit Wall Street. Sign up for the Wealth Daily newsletter below. You'll also get our free report, Marijuana Outlook: Best Stocks to Buy.
A Well-Known Evolutionary Process
It’s this sort of diversification, both in terms of products and in terms of core focus, that will allow Cannabis Corp. 2030 to turn into a multibillion-dollar company...
Much like Walmart (NYSE: WMT) did when it went from a tiny 5-and-10 cent store in Bentonville, Arkansas, to the retail giant it is today...
Or like McDonald's (NYSE: MCD) did when it transformed from a single burger joint into a globe-spanning brand with more than 30,000 locations and one of the world’s biggest real estate portfolios...
Or like Netflix (NASDAQ: NFLX) did when it went from a DVD rental company to the media giant it is today, with billions invested in licensing, as well as the production of its own movies and shows.
Now… Here Is Cannabis Corp. 2030’s Biggest Surprise of All
Everything I just told you about our hypothetical cannabis operation of the future is a lie, at its very core.
The company I just described won’t be doing all these things by the year 2030.
This company already exists and is already engaged in all of these business operations as you read this.
It has operations across the world. It leases its properties to client firms for the purpose of product development. It employs specialists in a wide range of fields and develops a wide range of products.
It’s even working on its own soft drink with the help of a former Coca-Cola executive who was hired specifically for that purpose.
And its stock is trading, right now, on two major North American exchanges.
The only thing is, this company, which is destined to become the Walmart, the McDonald's, the Netflix of the cannabis industry, is still in its preliminary stages.
While everything is in place for it to become the multibillion-dollar giant it’s destined to be, the commercialization aspect just isn’t quite there yet.
But that won’t be the case for long.
This time next year, you’ll most likely read about this company again, only this time, it won’t be in an email, but on the cover of some mainstream financial news outlet like Forbes or the Wall Street Journal.
By then, however, it will be too late. The biggest gains will have already been made.
You don’t have to miss out. You can join the campaign before it gains global investor attention.
All you have to do is click here and get the rest of this amazing story.
Fortune favors the bold,
Coming to us from an already impressive career as an independent trader and private investor, Alex's specialty is in the often misunderstood but highly profitable development-stage microcap sector. Focusing on young, aggressive, innovative biotech and technology firms from the U.S. and Canada, Alex has built a track record most Wall Street hedge funders would envy. Alex contributes his thoughts and insights regularly to Wealth Daily. To learn more about Alex, click here.
The Best Free Investment You'll Ever Make
After getting your report, you’ll begin receiving the Wealth Daily e-Letter, delivered to your inbox daily.